ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NHS green light for Novartis skin cancer combo
pharmatimes
November 01, 2018The NHS now has three months to ensure that Novartis’ combination therapy dabrafenib/trametinib is routinely available to eligible skin cancer patients, after cost regulators published guidance backing funds for the treatment.
Pharma Sources Insight January 2025
